phenylpiperazine has been researched along with lassbio-581 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barreiro, EJ; Dalla Costa, T; Eifler-Lima, VL; Fraga, CA; Menegatti, R; Neves, G; Rates, SM; Tasso, L | 1 |
| Barreiro, EJ; Betti, AH; Conrado, DJ; Fraga, CA; Kliemann, M; Neves, G; Rates, SM; Tasso, L | 1 |
2 other study(ies) available for phenylpiperazine and lassbio-581
| Article | Year |
|---|---|
Validated HPLC method for determination of LASSBio-581, a new heterocyclic N-phenylpiperazine derivative, in rat plasma.
Topics: Animals; Chromatography, High Pressure Liquid; Heterocyclic Compounds; Male; Piperazines; Rats; Rats, Wistar | 2003 |
Serotonergic neurotransmission mediates hypothermia induced by the N-phenylpiperazine antipsychotic prototypes LASSBio-579 and LASSBio-581.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Body Temperature; Haloperidol; Hypothermia; Injections, Intraperitoneal; Male; Mice; Piperazines; Pyridines; Serotonin; Serotonin Antagonists; Synaptic Transmission | 2008 |